Previous close | 2.0000 |
Open | 2.0000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 5.00 |
Expiry date | 2024-09-20 |
Day's range | 2.0000 - 2.0000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Insights into Arbutus Biopharma Corp's Q1 performance, including financial updates and progress in clinical trials.
Insights into Arbutus Biopharma's First Quarter Performance and Strategic Updates
Arbutus (ABUS) delivered earnings and revenue surprises of 0% and 28.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?